What is Omvoh?

Omvoh (mirikizumab-mrkz) is a biologic medication approved for the treatment of moderately to severely active ulcerative colitis (UC) and Crohn’s disease (CD) in adults. It functions by targeting the interleukin-23p19 (IL-23p19) protein, a key contributor to intestinal inflammation, thereby reducing inflammation in the gastrointestinal tract. The treatment regimen begins with intravenous (IV) infusions during the induction phase, followed by subcutaneous injections for maintenance therapy.

Side Effects

Headache
Injection site reactions (redness, swelling, pain)
Fatigue
Back pain
Throat or mouth pain (in cases of nasal polyps treatment)
Rash

Administration

Duration

30 minutes

Cycle

After initial 3 doses IV infusion, every 4 weeks self injections

Conditions Omvoh Treats

See what other infusions we offer

Information coming soon...

Check out our other treatments or contact us with any questions

Why Patients Choose Infusion to Recieve Their Omvoh Treatment

Infusion Specialists care for patients with complex chronic conditions by redefining the infusion therapy experience. They focus on patient-centered care that transcends traditional medical infusion treatments.

Redefine your care experience

Private Suites

Leather recliners and space for guests

On your Schedule

Local Centers offer flexible scheduling, including early morning, evenings, and weekends

Goodbye Waiting

Greeted by name at check-in, patient suites are always ready upon arrival

Sit Back and Relax

In-room streaming options and plenty of snacks